logo image
search icon
Electronic Drug Delivery Systems Market

Electronic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Wearable Infusion Pumps, Auto Injectors, Injection Pens, and Inhalers), By Application (Diabetes, Cardiovascular Disease (CVD), Respiratory Disorders, Multiple Sclerosis ), By Distribution Channel, By Region, And Segment Forecasts, 2024-2031

Report ID : 1736 | Published : 2024-03-28 | Pages: 180 | Format: PDF/EXCEL

The Global Electronic Drug Delivery Systems Market Size is valued at 11.02 billion in 2023 and is predicted to reach 18.81 billion by the year 2031 at a 7.06% CAGR during the forecast period for 2024-2031.

Electronic Drug Delivery Systems Market

Electronic drug delivery systems, or "smart drug delivery devices," are particularly well adapted to home care settings. These developments increase the value of obsolete tools, which also increases their usefulness and applicability. The rise in the incidence of target diseases is the main factor causing the market for electronic drug delivery systems to expand quickly. 

In addition, favorable reimbursement policies in essential markets, rapid technological and design developments, a rise in the incidence of chronic diseases, and a rise in the number of elderly patients are all anticipated to contribute to the growth of the demand for electronic drug delivery systems.

The market for electronic drug delivery systems is constrained by high initial R&D expenditures and strict regulations, whereas the unfavorable reimbursement structure in emerging nations will impede market expansion.

Moreover, the market for electronic drug delivery systems will have plenty of growth prospects due to rising healthcare costs and strong demand for biologics and mAbs. 

Recent Developments:

  • In April 2022, Halozyme Therapeutics, Inc. and Antares Pharma, Inc. announced that they would sign a contract under which Halozyme would buy Antares for USD 5.60 in cash per share. The acquisition, which values Antares at around USD 960 million, was approved by the boards of directors of Halozyme and Antares unanimously. A market-leading specialized product and drug delivery company will be created due to Halozyme and Antares' merger.
  • In August 2019, the successful acquisition of BlueRock Therapeutics for USD 1 billion was announced by Bayer AG. The company works in the field of regenerative medicine. 

Competitive Landscape:

Some of the major key players in the electronic drug delivery systems market are:

  • Bayer AG
  • Gerresheimer AG
  • Medtronic
  • Elcam Medical
  • Novo Nordisk A/S
  • Insulet Corporation
  • BD
  • Sanofi
  • Frederick Furness Publishing
  • United Therapeutics Corporation
  • AstraZeneca
  • Tandem Diabetes Care
  • Merck Group Amgen
  • United Therapeutics Corporation
  • Hoffmann-La Roche
  • Companion Medical

Market Segmentation:

The electronic drug delivery systems market is segmented based on type, application and distribution channel. Based on type, the market is segregated as Wearable Infusion Pumps, Auto Injectors, Injection Pens and Inhalers. By application, the market is segmented into Diabetes, Cardiovascular Disease (CVD), Respiratory Disorders, Multiple Sclerosis and Others. Based on type, the market is segregated into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.

By Type, The Market For Electronic Drug Delivery Systems Is Significantly Impacted By The Wearable Infusion Pump Segment

The wearable infusion pumps category is expected to hold a major share in the global electronic drug delivery systems market in 2024. This is a result of the device's growing use in the effective management of chronic diseases like diabetes. Patients are less likely to use traditional pumps since they are more expensive and challenging to use. Recent smaller wearable pumps that provide equivalent health results to conventional therapy have promoted changes in patient behavior.

Online Pharmacies Segment Witnessed Growth At A Rapid Rate

The online pharmacies segment is projected to grow at a rapid rate in the global electronic drug delivery systems market. This results from more people using easy-to-use online pharmacies to buy prescription drugs. Given the importance of the internet in our lives, the move of pharmacies to an online platform was not unexpected. Studies show that ordering prescription drugs online can save consumers up to one-third of their overall costs. Patients gain a lot from e-pharmacy because it offers more options than a traditional pharmacy.

The North America Electronic Drug Delivery Systems Market Holds A Significant Revenue Share In The Region

Electronic drug delivery systems are used to treat diabetes and epilepsy and are increasingly used to treat a variety of chronic conditions, including diabetes. As a result, the North American market for electronic drug delivery systems is expected to record the highest market share in terms of revenue in the near future. In addition, the efforts of numerous manufacturers to develop intelligent solutions that can be tailored to the patient's experience are driving market revenue growth.

In addition, the Asia Pacific region is anticipated to grow swiftly in the global market for electronic drug delivery systems. This is due to the prevalence of chronic diseases such as diabetes, the increasing demand for sophisticated drug delivery platforms, and increased efforts to produce biosimilars. For example, the prevalence of type 2 diabetes has grown significantly in Asia and China over the past few decades, despite the fact that the global incidence of diabetes has increased over the same time period. 

Electronic Drug Delivery Systems Market Report Scope:

Report Attribute

Specifications

Market size value in 2023

USD 11.02 Bn

Revenue forecast in 2031

USD 18.81 Bn

Growth rate CAGR

CAGR of 7.06% from 2024 to 2031

Quantitative units

Representation of revenue in US$ Billion, volume (units) and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

Type, Application And Distribution Channel

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Competitive Landscape

Bayer AG, Gerresheimer AG, Medtronic, Elcam Medical, Novo Nordisk A/S, Insulet Corporation, Becton and Dickinson Company (BD), Sanofi and Frederick Furness Publishing.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Electronic Drug Delivery Systems Market Snapshot

Chapter 4. Global Electronic Drug Delivery Systems Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:

5.2.1. Wearable Infusion Pumps
5.2.2. Auto Injectors
5.2.3. Injection Pens
5.2.4. Inhalers

Chapter 6. Market Segmentation 2: by Distribution Channel Estimates & Trend Analysis
6.1. by Distribution Channel & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:

6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies

Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

7.2.1. Diabetes
7.2.2. Cardiovascular Disease (CVD)
7.2.3. Respiratory Disorders
7.2.4. Multiple Sclerosis
7.2.5. Others

Chapter 8. Electronic Drug Delivery Systems Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.1.2. North America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.1.3. North America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.4. North America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.2. Europe

8.2.1. Europe Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.2.2. Europe Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.2.3. Europe Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. Europe Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.3.2. Asia Pacific Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.3.3. Asia-Pacific Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Asia Pacific Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.4. Latin America

8.4.1. Latin America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.4.2. Latin America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.4.3. Latin America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.4. Latin America Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.5.2. Middle East & Africa Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.5.3. Middle East & Africa Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Middle East & Africa Electronic Drug Delivery Systems Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles


9.2.1. Bayer AG
9.2.2. Gerresheimer AG
9.2.3. Medtronic
9.2.4. Elcam Medical
9.2.5. Novo Nordisk A/S
9.2.6. Insulet Corporation
9.2.7. BD
9.2.8. Sanofi
9.2.9. Frederick Furness Publishing
9.2.10. United Therapeutics Corporation
9.2.11. AstraZeneca
9.2.12. Tandem Diabetes Care
9.2.13. Merck Group Amgen
9.2.14. United Therapeutics Corporation
9.2.15. F. Hoffmann-La Roche
9.2.16. Companion Medical
9.2.17. Other Prominent Players

Segmentation of Electronic Drug Delivery Systems Market-

Electronic Drug Delivery Systems Market By Type

  • Wearable Infusion Pumps
  • Auto Injectors
  • Injection Pens
  • Inhalers 

Electronic Drug Delivery Systems Market

Electronic Drug Delivery Systems Market By Application

  • Diabetes
  • Cardiovascular Disease (CVD)
  • Respiratory Disorders
  • Multiple Sclerosis
  • Others

Electronic Drug Delivery Systems Market By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Electronic Drug Delivery Systems Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Electronic Drug Delivery Systems Market?

Electronic Drug Delivery Systems Market expected to grow at a 7.06% CAGR during the forecast period for 2024-2031

Bayer AG, Gerresheimer AG, Medtronic, Elcam Medical, Novo Nordisk A/S, Insulet Corporation, Becton and Dickinson Company (BD)

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach